Stockreport

Alimera Sciences Launches ILUVIEN® in Germany For Non-Infectious Uveitis Indication

Alimera Sciences, Inc.  (ALIM) 
Last alimera sciences, inc. earnings: 4/29 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alimerasciences.com/investor-relations
PDF ATLANTA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophtha [Read more]